Target intelligence / Profile preview

Even-skipped homeobox 1 (EVX1)

Target
EVX1
Molecular classification
Transcription factor, Homeobox domain protein
01

Overview

Even-skipped homeobox 1 (EVX1) is a transcription factor belonging to the homeobox gene family, containing a DNA-binding homeodomain highly homologous to the Drosophila even-skipped (eve) segmentation gene. EVX1 functions primarily as a transcriptional repressor during embryogenesis, playing key roles in the specification of neuronal cell types and normal blastocyst development. In prostate cancer, EVX1 is frequently hypermethylated, which is associated with reduced gene expression and poor clinical outcomes, making its methylation a potential biomarker for disease progression. Mutations in EVX1 are linked to congenital limb and urogenital malformations. EVX1 does not represent a common therapeutic target such as a receptor or enzyme, but has mechanistic and biomarker importance in development and cancer.

Other names
Homeobox even-skipped homolog protein 1EVX1EVX-1eveeven-skipped homeobox homolog 1even-skipped homeo box 1 (homolog of Drosophila)
02

Biological functions

Transcriptional repressionEmbryonic developmentSpecification of neuronal cell typesRegulation of gene expression during development
03

Disease associations

Cancer (notably prostate cancer via aberrant methylation)Congenital malformations (Hand-Foot-Genital Syndrome, Preaxial Deficiency, Postaxial Polydactyly, Hypospadias)
04

Biomarkers

EVX1 methylation (prostate cancer recurrence predictor)

Beyond the preview

Go deeper on Even-skipped homeobox 1 (EVX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Even-skipped homeobox 1 (EVX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call